{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:40:32Z","timestamp":1760575232291,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejps.2023.106668","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T20:20:14Z","timestamp":1701894014000},"page":"106668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro trypanocidal potency and in vivo treatment efficacy of oligomeric ethylene glycol-tethered nitrofurantoin derivatives"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-9428","authenticated-orcid":false,"given":"Helena D.","family":"Janse van Rensburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"N'Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106668_bib0001","first-page":"1213","article-title":"Isolation of cycloeucalenol from Boophone disticha and evaluation of its cytotoxicity","volume":"8","author":"Adewusi","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejps.2023.106668_bib0002","series-title":"Encyclopedia of Psychopharmacology","article-title":"History of psychopharmacology","author":"Badiani","year":"2014"},{"key":"10.1016\/j.ejps.2023.106668_bib0003","series-title":"Trypanosomiasis, Canine and Feline Infectious Diseases","first-page":"760","author":"Barr","year":"2014"},{"key":"10.1016\/j.ejps.2023.106668_bib0004","first-page":"4140","article-title":"Scientific Opinion on nitrofurans and their metabolites in food","volume":"13","author":"Bendford","year":"2015","journal-title":"EFSA J."},{"key":"10.1016\/j.ejps.2023.106668_bib0005","series-title":"Case Studies in Drug discovery, Basic principles of Drug Discovery and Development","first-page":"511","author":"Blass","year":"2015"},{"key":"10.1016\/j.ejps.2023.106668_bib0006","series-title":"Infectious diseases, Color Atlas of Diseases and Disorders of Cattle E-Book","first-page":"238","author":"Blowey","year":"2011"},{"key":"10.1016\/j.ejps.2023.106668_bib0007","series-title":"Equine Emergencies","first-page":"656","article-title":"Emergency diseases outside the continental United States","author":"Borges","year":"2014"},{"key":"10.1016\/j.ejps.2023.106668_bib0008","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13071-019-3355-5","article-title":"African trypanosomes","volume":"12","author":"Cayla","year":"2019","journal-title":"Parasit. Vect."},{"key":"10.1016\/j.ejps.2023.106668_bib0009","doi-asserted-by":"crossref","first-page":"e1454","DOI":"10.1371\/journal.pntd.0001454","article-title":"High prevalence of drug resistance in animal trypanosomes without a history of drug exposure","volume":"5","author":"Chitanga","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2023.106668_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106668_bib0011","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000401065","article-title":"The pharmacokinetics of nitrofurantoin and its related bioavailability","volume":"25","author":"Conklin","year":"1978","journal-title":"Antibiot. Chemother. (1971)"},{"key":"10.1016\/j.ejps.2023.106668_bib0012","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1371\/journal.pntd.0000618","article-title":"Complete in vitro life cycle of Trypanosoma congolense: development of genetic tools","volume":"4","author":"Coustou","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2023.106668_bib0013","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00044-015-1475-9","article-title":"Fluorine-containing benzothiazole as a novel trypanocidal agent: design, in silico study, synthesis and activity evaluation","volume":"25","author":"Cuevas-Hern\u00e1ndez","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejps.2023.106668_bib0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drug."},{"key":"10.1016\/j.ejps.2023.106668_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13071-022-05190-1","article-title":"A review on the diagnosis of animal trypanosomoses","volume":"15","author":"Desquesnes","year":"2022","journal-title":"Parasit. Vect."},{"key":"10.1016\/j.ejps.2023.106668_bib0016","series-title":"Annual Reports in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/B978-0-12-386009-5.00004-7","article-title":"The future of drug repositioning: old drugs, new opportunities","author":"Doan","year":"2011"},{"key":"10.1016\/j.ejps.2023.106668_bib0017","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1021\/jf501351r","article-title":"Cysteine-conjugated metabolites of ginger components, shogaols, induce apoptosis through oxidative stress-mediated p53 pathway in human colon cancer cells","volume":"62","author":"Fu","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejps.2023.106668_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115104","article-title":"Nitrofuran drugs beyond redox cycling: evidence of Nitroreduction-independent cytotoxicity mechanism","volume":"401","author":"Gallardo-Garrido","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106668_bib0019","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/200285a0","article-title":"Prophylactic activity of suramin complexes in \u2018Surra\u2019(Trypanosoma evansi)","volume":"200","author":"Gill","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106668_bib0020","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy: a review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.ejps.2023.106668_bib0021","series-title":"Advances in Cancer Research","first-page":"133","article-title":"Mass spectrometry imaging in oncology drug discovery","author":"Goodwin","year":"2017"},{"key":"10.1016\/j.ejps.2023.106668_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2023.106668_bib0023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-5793(85)80732-8","article-title":"Superoxide dismutase inhibits the superoxide-driven Fenton reaction at two different levels: implications for a wider protective role","volume":"185","author":"Gutteridge","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2023.106668_bib0024","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.01213-09","article-title":"Exploiting the drug-activating properties of a novel trypanosomal nitroreductase","volume":"54","author":"Hall","year":"2010","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.ejps.2023.106668_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejps.2023.106668_bib0026","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S0031182000062533","article-title":"In vitro cultivation of Trypanosoma congolense bloodstream forms in the absence of feeder cell layers","volume":"102","author":"Hirumi","year":"1991","journal-title":"Parasitology"},{"key":"10.1016\/j.ejps.2023.106668_bib0027","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molbiopara.2014.05.001","article-title":"Antigenic variation in African trypanosomes","volume":"195","author":"Horn","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejps.2023.106668_bib0028","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/jf062902a","article-title":"Determinations of residual furazolidone and its metabolite, 3-amino-2-oxazolidinone (AOZ), in fish feeds by HPLC-UV and LC-MS\/MS, respectively","volume":"55","author":"Hu","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejps.2023.106668_bib0029","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106668_bib0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/ph15020128","article-title":"Discovery, development, inventions and patent review of fexinidazole: the first all-oral therapy for Human African Trypanosomiasis","volume":"15","author":"Imran","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2023.106668_bib0031","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0039-9140(97)00017-9","article-title":"A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability","volume":"44","author":"Ishiyama","year":"1997","journal-title":"Talanta"},{"key":"10.1016\/j.ejps.2023.106668_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning","volume":"10","author":"Kaiser","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2023.106668_bib0033","article-title":"An update on African trypanocide pharmaceutics and resistance","volume":"9","author":"Kasozi","year":"2022","journal-title":"Front. Veterin. Sci."},{"key":"10.1016\/j.ejps.2023.106668_bib0034","first-page":"2021","article-title":"Prevalence of Trypanosoma congolense and Trypanosoma vivax in Lira District, Uganda","author":"Katabazi","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejps.2023.106668_bib0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2023.106668_bib0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106668_bib0037","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/md15100329","article-title":"Marine-derived Penicillium species as producers of cytotoxic metabolites","volume":"15","author":"Liu","year":"2017","journal-title":"Mar. Drug."},{"year":"2022","series-title":"Nitrofurans Use in Animals","author":"Mercer","key":"10.1016\/j.ejps.2023.106668_bib0038"},{"key":"10.1016\/j.ejps.2023.106668_bib0039","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00436-017-5542-7","article-title":"Oral administration of azithromycin ameliorates trypanosomosis in Trypanosoma congolense-infected mice","volume":"116","author":"Molefe","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejps.2023.106668_bib0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pt.2016.04.012","article-title":"Animal African trypanosomiasis: time to increase focus on clinically relevant parasite and host species","volume":"32","author":"Morrison","year":"2016","journal-title":"Trend. Parasitol."},{"key":"10.1016\/j.ejps.2023.106668_bib0041","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13071-014-0603-6","article-title":"The burden and spatial distribution of bovine African trypanosomes in small holder crop-livestock production systems in Tororo District, south-eastern Uganda","volume":"7","author":"Muhanguzi","year":"2014","journal-title":"Parasit. Vect."},{"key":"10.1016\/j.ejps.2023.106668_bib0042","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.3390\/molecules26113372","article-title":"Vitro and in vivo trypanocidal efficacy of synthesized nitrofurantoin analogs","volume":"26","author":"Munsimbwe","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2023.106668_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116253","article-title":"Synthesis and evaluation of trypanocidal activity of derivatives of naturally occurring 2, 5-diphenyloxazoles","volume":"42","author":"Narita","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106668_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200529","article-title":"Exploration of ethylene glycol linked nitrofurantoin derivatives against Leishmania: synthesis and in vitro activity","author":"Ndlovu","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejps.2023.106668_bib0045","series-title":"Vaccines For Biodefense and Emerging and Neglected Diseases","first-page":"1258","article-title":"African trypanosomiasis","author":"Nok","year":"2009"},{"key":"10.1016\/j.ejps.2023.106668_bib0046","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2023.106668_bib0047","series-title":"Veterinary Reproduction and Obstetrics","first-page":"541","article-title":"Equine infertility and stud medicine practice","author":"Paccamonti","year":"2019"},{"key":"10.1016\/j.ejps.2023.106668_bib0048","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pathmechdis-031621-025153","article-title":"The pathogenesis of african trypanosomiasis","volume":"18","author":"Pays","year":"2023","journal-title":"Ann. Rev. Pathol.: Mechan. Dis."},{"key":"10.1016\/j.ejps.2023.106668_bib0049","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0001-706X(93)90092-P","article-title":"Pharmacology of diminazene: a review","volume":"54","author":"Peregrine","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejps.2023.106668_bib0050","first-page":"354","article-title":"The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter","volume":"110","author":"Raaflaub","year":"1980","journal-title":"Schweiz. Med. Wochenschr."},{"key":"10.1016\/j.ejps.2023.106668_bib0051","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1574-6976.2008.00107.x","article-title":"Reduction of polynitroaromatic compounds: the bacterial nitroreductases","volume":"32","author":"Rold\u00e1n","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejps.2023.106668_bib0052","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.drudis.2013.07.002","article-title":"Integration of models and experimentation to optimise the production of potential biotherapeutics","volume":"18","author":"Royle","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2023.106668_bib0053","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1111\/bph.13571","article-title":"Azoreductases in drug metabolism","volume":"174","author":"Ryan","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106668_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628144","article-title":"Drug repurposing strategy (DRS): emerging approach to identify potential therapeutics for treatment of novel coronavirus infection","volume":"8","author":"Sahoo","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejps.2023.106668_bib0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/092986711793979779","article-title":"Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease","volume":"18","author":"Salas","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106668_bib0056","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.prevetmed.2015.06.013","article-title":"Mapping the benefit-cost ratios of interventions against bovine trypanosomosis in Eastern Africa","volume":"122","author":"Shaw","year":"2015","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.ejps.2023.106668_bib0057","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/AAC.00332-10","article-title":"Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis","volume":"54","author":"Sokolova","year":"2010","journal-title":"Antimicrob. Agent. Chemother."},{"key":"10.1016\/j.ejps.2023.106668_bib0058","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S0103-50532002000100002","article-title":"Poly (ethylene glycol) or Poly (ethylene oxide)?: magnitude of end-group Contribution to the Partitioning of Ethylene Oxide Oligomers and Polymers between Water and Organic Phases","volume":"13","author":"Spitzer","year":"2002","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejps.2023.106668_bib0059","series-title":"The Small Molecule Drug Discovery Process\u2013From Target Selection to Candidate selection, Introduction to Biological and Small Molecule Drug Research and Development","first-page":"81","author":"Stocks","year":"2013"},{"key":"10.1016\/j.ejps.2023.106668_bib0060","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1292\/jvms.14-0273","article-title":"Establishment of ATP-based luciferase viability assay in 96-well plate for Trypanosoma congolense","volume":"76","author":"Suganuma","year":"2014","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejps.2023.106668_bib0061","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/pathogens11030331","article-title":"Therapeutic efficacy of orally administered nitrofurantoin against animal African trypanosomosis caused by Trypanosoma congolense infection","volume":"11","author":"Suganuma","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ejps.2023.106668_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1755-3","article-title":"Isolation, cultivation and molecular characterization of a new Trypanosoma equiperdum strain in Mongolia","volume":"9","author":"Suganuma","year":"2016","journal-title":"Parasit Vect."},{"key":"10.1016\/j.ejps.2023.106668_bib0063","first-page":"200","article-title":"The establishment of in vitro culture and drug screening systems for a newly isolated strain of Trypanosoma equiperdum","volume":"7","author":"Suganuma","year":"2017","journal-title":"Int. J. Parasitol.: Drug. Drug Resist."},{"year":"2000","series-title":"Impacts of Trypanosomiasis on African Agriculture","author":"Swallow","key":"10.1016\/j.ejps.2023.106668_bib0064"},{"key":"10.1016\/j.ejps.2023.106668_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10837450.2019.1689401","article-title":"Formulation strategy of nitrofurantoin: co-crystal or solid dispersion?","volume":"25","author":"Teoh","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2023.106668_bib0066","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.polymer.2007.10.029","article-title":"Synthesis and applications of heterobifunctional poly (ethylene oxide) oligomers","volume":"49","author":"Thompson","year":"2008","journal-title":"Polym. (Guildf)"},{"key":"10.1016\/j.ejps.2023.106668_bib0067","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/a809656b","article-title":"A water-soluble tetrazolium salt useful for colorimetric cell viability assay","volume":"36","author":"Tominaga","year":"1999","journal-title":"Anal. Commun."},{"key":"10.1016\/j.ejps.2023.106668_bib0068","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11094-005-0161-5","article-title":"Hydrolytic and reductive transformations of nifuroxazide","volume":"39","author":"Trukhacheva","year":"2005","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejps.2023.106668_bib0069","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/bm701067d","article-title":"Heterobifunctional poly (ethylene oxide) oligomers containing carboxylic acids","volume":"9","author":"Vadala","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejps.2023.106668_bib0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"Van De Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2023.106668_bib0071","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein LI is the trypanosome lytic factor of human serum","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106668_bib0072","doi-asserted-by":"crossref","first-page":"469","DOI":"10.17221\/1979-VETMED","article-title":"Nitrofuran antibiotics: a review on the application, prohibition and residual analysis","volume":"53","author":"Vass","year":"2008","journal-title":"Vet. Med. (Praha)"},{"key":"10.1016\/j.ejps.2023.106668_bib0073","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106668_bib0074","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/microorganisms10071298","article-title":"Current treatments to control African trypanosomiasis and one health perspective","volume":"10","author":"Venturelli","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejps.2023.106668_bib0075","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1080\/07391102.2016.1195283","article-title":"Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data","volume":"35","author":"Vera","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejps.2023.106668_bib0076","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1081-1206(10)61904-7","article-title":"Does potency predict clinical efficacy? Illustration through an antihistamine model","volume":"89","author":"Waldman","year":"2002","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejps.2023.106668_bib0077","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/AAC.35.1.158","article-title":"Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia","volume":"35","author":"Walzer","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2023.106668_bib0078","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1289\/ehp.8564309","article-title":"Some reactions and properties of nitro radical-anions important in biology and medicine","volume":"64","author":"Wardman","year":"1985","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejps.2023.106668_bib0079","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1747-0285.2006.00391.x","article-title":"Searching for new antimalarial therapeutics amongst known drugs","volume":"67","author":"Weisman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"year":"2023","series-title":"Trypanosomiasis, Human African (Sleeping Sickness)","key":"10.1016\/j.ejps.2023.106668_bib0080"},{"year":"2022","series-title":"Trypanosomiasis in Animals","author":"Wilkowsky","key":"10.1016\/j.ejps.2023.106668_bib0081"},{"key":"10.1016\/j.ejps.2023.106668_bib0082","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.drudis.2022.05.026","article-title":"Drug repurposing: an effective strategy to accelerate contemporary drug discovery","volume":"27","author":"Zhan","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2023.106668_bib0083","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chembiol.2012.05.017","article-title":"ALDH2 mediates 5-nitrofuran activity in multiple species","volume":"19","author":"Zhou","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejps.2023.106668_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105092","article-title":"An update on derivatisation and repurposing of clinical nitrofuran drugs","volume":"140","author":"Zuma","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106668_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115012","article-title":"Synthesis and in vitro antileishmanial activity of alkylene-linked nitrofurantoin-triazole hybrids","volume":"246","author":"Zuma","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106668_bib0086","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200023","article-title":"Synthesis, in vitro Antileishmanial Efficacy and Hit\/Lead Identification of Nitrofurantoin-Triazole Hybrids","volume":"17","author":"Zuma","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2023.106668_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103587","article-title":"Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues","volume":"96","author":"Zuma","year":"2020","journal-title":"Bioorg. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:13:06Z","timestamp":1760530386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":87,"alternative-id":["S0928098723002968"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106668","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro trypanocidal potency and in vivo treatment efficacy of oligomeric ethylene glycol-tethered nitrofurantoin derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106668"}}